$VIR
Vir Biotechnology, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$11.17
▼-1.06%-$0.120
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateVir Biotechnology, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is VIR down today? It is at $11.17 (-1.06%), and our scanner flagged it 63 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VIR spikes, and full due diligence on VIR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $VIR 63 times in the last 30 days. Create a free account to track $VIR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on VIR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VIR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
The company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
17,647,059 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · Priced at $8.5/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
More Robert J Director | Sold (automatic/other) | -8K | sold 16% | 41K | n/a | Aug 11, 26 |
More Robert J Director | Acquired (grant/award) | +8K | added 1.6% | 518K | n/a | Aug 11, 26 |
Coughlin Timothy Director | Acquired (grant/award) | +16K | n/a | 16K | n/a | Jun 9, 26 |
Sabatini Brent Officer | Sold (automatic/other) | -379 | sold 0.6% | 62K | $4K at $9.45 | Jun 1, 26 |
Napolitano Janet Director | Sold (automatic/other) | -3K | sold 13% | 21K | $30K at $9.45 | Jun 1, 26 |
Bischofberger Norbert W Director | Acquired (grant/award) | +8K | added 60% | 21K | n/a | May 27, 26 |
Farid Ramy Director | Acquired (grant/award) | +8K | added 33% | 32K | n/a | May 27, 26 |
Hatfield Jeffrey S. Director | Acquired (grant/award) | +8K | added 25% | 40K | n/a | May 27, 26 |
More Robert J Director | Acquired (grant/award) | +8K | added 20% | 49K | n/a | May 27, 26 |
Napolitano Janet Director | Acquired (grant/award) | +8K | added 49% | 24K | n/a | May 27, 26 |
Sigal Charles Elliott Director | Acquired (grant/award) | +8K | added 25% | 40K | n/a | May 27, 26 |
Sato Vicki L Director | Sold (automatic/other) | -22K 0.01% of company | sold 2.0% | 1.08M | $221K at $10.05 | May 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on VIR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VIR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
VIR last traded at $11.17, down 1.06% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Vir Biotechnology, Inc. Common Stock (VIR) is next expected to report earnings on Wednesday, November 4, 2026, about 31 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. VIR currently has a dividend yield of about 0.90% ($0.10 per share per year). Dividend figures can change; this is not investment advice.
The VIR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VIR 63 times in the last 30 days.
VIR (Vir Biotechnology, Inc. Common Stock) trades on XNAS, with a market cap of about $1.89B in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VIR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$VIR discussion
Sign in to ask a question or join the discussion.